- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about CH:NOVN
Recent news which mentions CH:NOVN
From MarketWatch
Novartis spinoff Sandoz valued at $11.2 billion in trading debut
October 04, 2023
Tickers
NVS
From MarketWatch
As Ozempic/Wegovy frenzy continues, Morgan Stanley lifts forecasts for weight-loss drugs to $77 billion
July 21, 2023
From MarketWatch
From MarketWatch
From MarketWatch
Tickers
NVS
From MarketWatch
Novartis gets positive result from breast-cancer drug trial
March 27, 2023
Tags
CH:NOVN
From MarketWatch
Novartis posts lower sales and profit on generic competition, but boosts 2022 dividend
February 01, 2023
Tickers
NVS
From MarketWatch
Novartis prostate cancer drug trial meets primary endpoint
December 05, 2022
Tickers
NVS
From MarketWatch
Tickers
NVS
From MarketWatch
Novartis hemoglobinuria trial meets two primary endpoints
October 24, 2022
Tickers
NVS
From MarketWatch
Novartis says authorities investigating a patent assertion
September 15, 2022
Tickers
NVS
From MarketWatch
AstraZeneca, Eli Lilly and Roche among pharmaceutical companies upgraded for high returns on R&D investments, analysts say
September 14, 2022
From MarketWatch
Fed heroics or no, the S&P 500 level is destined for a retest of lows. These are the levels to watch, says this strategist
August 25, 2022
From MarketWatch
This group of stocks is flagging a rebound, and that’s good news for the S&P 500, says technical analyst
March 22, 2022
From MarketWatch
AT&T and 4 more unloved dividend stocks to buy in a ‘risk-off’ era
January 31, 2022
From MarketWatch
From MarketWatch
From MarketWatch
Europe stocks beat back omicron worries to rise alongside global stocks
December 23, 2021
Tickers
NVS
From MarketWatch
Europe stocks head for a fresh record close, led by Roche and oil giants
November 04, 2021
From MarketWatch
Europe stocks off highs as Deutsche Bank slides after results
October 27, 2021
From MarketWatch
European stocks slump as worries spread about COVID’s global growth
September 08, 2021
From MarketWatch
Rebound from Monday’s rout continues with Dow futures up 200 points and European equities higher
July 21, 2021
From MarketWatch
From MarketWatch
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.